1. A Japanese herbal medicine (kampo), hochuekkito (TJ-41), has anti-inflammatory effects on the chronic obstructive pulmonary disease mouse model.
- Author
-
Yuki M, Ishimori T, Kono S, Nagoshi S, Saito M, Isago H, Tamiya H, Fukuda K, Miyashita N, Ishii T, Matsuzaki H, Hiraishi Y, Saito A, Jo T, Nagase T, and Mitani A
- Subjects
- Animals, Male, Mice, AMP-Activated Protein Kinases metabolism, Cell Line, Cytokines metabolism, Lipopolysaccharides, Lung pathology, Lung drug effects, Lung metabolism, Pancreatic Elastase metabolism, Signal Transduction drug effects, TOR Serine-Threonine Kinases metabolism, Anti-Inflammatory Agents pharmacology, Disease Models, Animal, Medicine, Kampo, Pulmonary Disease, Chronic Obstructive drug therapy, Pulmonary Disease, Chronic Obstructive metabolism, Pulmonary Disease, Chronic Obstructive pathology
- Abstract
Chronic obstructive pulmonary disease (COPD) is a progressive disease that is characterized by chronic airway inflammation. A Japanese herbal medicine, hochuekkito (TJ-41), is prominently used for chronic inflammatory diseases in Japan. This study aimed to analyze the anti-inflammatory effect of TJ-41 in vivo and its underlying mechanisms. We created a COPD mouse model using intratracheal administration of porcine pancreatic elastase and lipopolysaccharide (LPS) and analyzed them with and without TJ-41 administration. A TJ-41-containing diet reduced inflammatory cell infiltration of the lungs in the acute and chronic phases and body weight loss in the acute phase. In vitro experiments revealed that TJ-41 treatment suppressed the LPS-induced inflammatory cytokines in BEAS-2B cells. Furthermore, TJ-41 administration activated the AMP-activated protein kinase (AMPK) pathway and inhibited the mechanistic target of the rapamycin (mTOR) pathway, both in cellular and mouse experiments. We concluded that TJ-41 administration reduced airway inflammation in the COPD mouse model, which might be regulated by the activated AMPK pathway, and inhibited the mTOR pathway., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF